Sarah Eversman
Creighton University, Mayo Clinic in Florida, Mayo Clinic Hospital
Papers
4
Total Citations
82
H-Index
3
About
Sarah Eversman is a leading urologic surgeon and researcher at the Mayo Clinic, whose work is redefining the standards of care for complex bladder and vascular surgeries. Her primary research focuses on the comparative effectiveness of robotic-assisted versus open surgical techniques, particularly for radical cystectomy and vena cava procedures. Eversman’s landmark study, "Robot Assisted Radical Cystectomy vs Open Radical Cystectomy," with 39 citations, provides over a decade of evidence demonstrating that robotic approaches can offer comparable oncologic outcomes with reduced morbidity. She has also pioneered techniques for robotic surgery of the inferior vena cava, as detailed in her 2019 paper, which has been cited 20 times for its insights on perioperative outcomes and long-term patency. Additionally, her 2021 work on intracorporeal urinary diversion, also with 20 citations, has significantly advanced understanding of how surgical approach impacts ureteroenteric stricture rates. Eversman’s contributions are not only technical but also practical, as she has elucidated how drugs like alvimopan can be optimized for different surgical contexts. Her cumulative work, with over 80 citations, positions her as a key architect of minimally invasive urologic oncology, directly improving patient recovery and surgical safety.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4